Current status of drug therapy for alveolar echinococcosis

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Nov 27, 2024; 16(11): 1243-1254
Published online Nov 27, 2024. doi: 10.4254/wjh.v16.i11.1243

Table 3 Natural compound anti-alveolar echinococcosis therapy

Treatment plan	**In vitro or in vivo**	Treatment effect
Asparagusic acid	In vitro + in vivo	Better therapeutic effect
Crocin	In vitro + in vivo	Better therapeutic effect
Allicin	In vitro + in vivo	Better therapeutic effect
Thymus capitatus essential oil	In vitro	Inhibit E. multilocularis growth
Ampelopsin	In vitro	Inhibit E. multilocularis growth
Menthol	In vitro + in vivo	Better therapeutic effect
Osthole	In vitro + in vivo	Better therapeutic effect
Punica granatum peel extract	In vitro + in vivo	Better therapeutic effect
Matrine	In vitro + in vivo	Better therapeutic effect
Curcumin	In vitro + in vivo	Better therapeutic effect

Citation: Jing QD, A JD, Liu LX, Fan HN. Current status of drug therapy for alveolar echinococcosis. World J Hepatol 2024; 16(11): 1243-1254
URL: https://www.wjgnet.com/1948-5182/full/v16/i11/1243.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i11.1243

Jing QD, A JD, Liu LX, Fan HN. Current status of drug therapy for alveolar echinococcosis. World J Hepatol 2024; 16(11): 1243-1254 [PMID: 39606163 DOI: 10.4254/wjh.v16.i11.1243]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.